Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.42 USD | -2.84% |
|
-7.07% | -33.46% |
06-11 | Transcript : Vistagen Therapeutics, Inc., Q4 2024 Earnings Call, Jun 11, 2024 | |
06-11 | Vistagen Therapeutics, Inc. Reports Earnings Results for the Full Year Ended March 31, 2024 | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-33.46% | 92.43M | |
+16.42% | 122B | |
+19.02% | 113B | |
+3.14% | 22.66B | |
-16.20% | 21.34B | |
-39.57% | 16.92B | |
-11.63% | 16.68B | |
-16.24% | 16.61B | |
+2.68% | 13.62B | |
+21.16% | 11.04B |
- Stock Market
- Equities
- VTGN Stock
- News Vistagen Therapeutics, Inc.
- Transcript : Vistagen Therapeutics, Inc., Q2 2024 Earnings Call, Nov 09, 2023